ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

Robert Day Advocates NCI Payment for Investigator Salaries

May 7, 1999

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

June 6, 2014

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

June 24, 2011

OCEANS Study: Avastin Shows Tumor Shrinkage in 79 Percent

June 24, 2011

NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility

September 7, 1990